Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-31 @ 11:38 AM
Study NCT ID:
NCT07428018
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-05
First Post:
2026-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib
Sponsor:
Mario Negri Institute for Pharmacological Research
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-04-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2026-02-17
First Submit QC Date:
None
Study First Post Date:
2026-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-03
Last Update Post Date:
2026-03-05
Last Update Post Date Type:
ACTUAL